Health insurance; coverage for at-home blood pressure monitors, report.
Summary
HB2208 requires health insurance coverage for at-home blood pressure monitors for individuals with a high-risk pregnancy, as determined by a licensed medical provider. The bill defines an at-home blood pressure monitor as an FDA-cleared or approved device intended for self-monitoring outside a clinical setting, and it specifies that hypertension includes prehypertension, essential hypertension, and secondary hypertension.
The mandate applies to individual and group accident and sickness policies, subscription contracts, and health care plans offered by health maintenance organizations. Covered plans must pay for one monitor every two years, or more often if medically necessary, and must also replace a monitor if it is lost, damaged, or needs updating because of changes in medical guidelines or technology. The bill bars copayments or other fees for the monitor and excludes certain limited policies, short-term policies, and Medicare-related or similar government plans.
Impact
The bill adds a new section, 38.2-3418.22, to the Virginia Insurance Code and also amends 38.2-4319 to incorporate that new mandate into the statutory framework governing health maintenance organizations. It expands the list of required health insurance benefits in Virginia by creating a specific coverage requirement for a pregnancy-related medical device, and it directs the Bureau of Insurance, in consultation with the Department of Health, to issue implementation guidelines and monitor compliance. The Bureau must also report annually beginning December 1, 2026, on utilization, premium impacts, and recommendations. The mandate applies to policies, contracts, and plans issued or renewed on or after January 1, 2026.
Sentiment
The bill appears to have received mixed but ultimately favorable committee support. It advanced from a subcommittee by a narrow 4-3 vote and then from the House Labor and Commerce Committee by a 12-10 vote, indicating support was present but not overwhelming. The available record shows no transcript discussion, so the main evidence of sentiment is the close voting pattern and the decision to report the bill with a substitute and send it to Appropriations.
Contention
The main points of contention likely involve the cost and scope of the insurance mandate. Opponents may be concerned about requiring insurers and HMOs to cover a device without copayments and to replace it under multiple circumstances, especially given the bill’s requirement for reporting on premium impacts. Supporters are likely focused on improving prenatal care and reducing risks associated with high-risk pregnancies through home monitoring. The close committee votes suggest disagreement over whether the public health benefits justify the added insurance costs and administrative burden.